Longevity Health net loss narrows 5% to $1.43 million in Q1 FY26

Longevity Health Holdings Inc. Ordinary Shares

XAGE

0.00

Longevity Health posted a net loss of USD 1.43 million for the three months ended March 31, 2026, narrowing 5% year over year.
Net sales fell 23% to USD 391,764.
Operating loss improved 12% to USD 1.33 million.
Cash totaled USD 313,396 at March 31, 2026, with negative working capital of USD 7.09 million.
Closed a PIPE on March 16, 2026 for gross proceeds of about USD 200,000; Janakiram Ajjarapu was appointed chairman and CEO effective that date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-224428), on May 15, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.